The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect ...
New Peptide MAM (multi-attribute method) workflow for the BioAccord LC-MS System monitors product quality attributes that can affect efficacy and safety of innovator drugs and biosimilars. End-to-end ...
The system was designed to enhance productivity, positioning the user to acquire and process data with a purpose-built LC-MS platform "The BioAccord LC-MS System was designed to optimize performance ...
Earlier in 2019, Waters Corporation announced their BioAccord LC-MS System for biopharmaceutical analysis. The BioAccord System is a self-calibrating, self-optimizing, self-sufficient tool that ...
Waters has introduced the BioAccord System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand access to high-resolution time-of-flight mass spectrometry ...
New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect ...
Business leaders attending the Pittcon scientific instrumentation conference in Philadelphia predicted growing markets for their increasingly web-connected instruments this year. But they ...
Waters Corporation WAT launched an integrated high-resolution liquid chromatography mass spectrometry (LC-MS) system, namely the Waters BioAccord System with ACQUITY Premier. The BioAccord System ...
Earlier in 2019, Waters Corporation announced their BioAccord LC-MS System for biopharmaceutical analysis. The BioAccord System is a self-calibrating, self-optimizing, self-sufficient tool that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results